[An enzyme-linked immunosorbent assay for measuring desmosine in vivo].
Pulmonary emphysema may be a disease in which some elastin in lung is lost. In order to evaluate lung elastin degradation, we developed an enzyme-linked immunosorbent assay for desmosine and measured urinary desmosine excretion and serum desmosine levels in healthy individuals and patients with pulmonary emphysema and other chronic pulmonary disorders. The measurement was performed by the inhibition technique of ELISA so that the samples had to be applied to CF11 cellulose mini-column for partial purification of desmosine. Total urinary excretion of desmosine was uniformly low in healthy individuals and patients with lung cancer, but urinary desmosine was elevated in some cases of pulmonary emphysema and diffuse panbronchiolitis. Using this ELISA method, more than 0.06 micrograms/ml serum desmosine concentration could be measured in 3 out of 25 healthy subjects who had never smoked (13.6%), 4/9 healthy current smokers (44.4%) and 19/26 patients with pulmonary emphysema (73.1%). Mean serum desmosine levels of meseared 19 cases of empysema were 0.182 micrograms/ml. It has been reported that approximately 15% of smokers develop pulmonary emphysema. The most important problem now is whether smokers with elevated urinary desmosine or with high serum desmosine will eventuality develop pulmonary emphysema.
Nishimura
K
K
D000596:Amino Acids / Q000032:analysis*; D001988:Bronchiolitis / Q000378:metabolism; D002908:Chronic Disease; D003895:Desmosine / Q000032:analysis* / Q000097:blood / Q000652:urine; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D006801:Humans; D011656:Pulmonary Emphysema / Q000378:metabolism*
D000596:Amino Acids; D003895:Desmosine